Rameen Beroukhim

Broad Institute

Full Professor(heuristic)

Glioma Diagnosis and Treatment · Genetics

Compare more Genetics professors.

h-index150
i10-index302
Publications892
Citations135,609

Grants

8 total · 2 active

NIH #R01CA303137

Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade glioma

Active
Amount
$700K–$800K
Period
2026-06-05 → 2031-05-31
PIs
2

Awarded at DANA-FARBER CANCER INST

NIH #R01CA262462

Synthetic lethalities to cell cycle disruption in glioma

Active
Amount
$600K–$700K
Period
2022-05-13 → 2027-04-30
PIs
2

Awarded at DANA-FARBER CANCER INST

NIH #U24CA264029

Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing Data

Amount
$300K–$400K
Period
2021-09-20 → 2026-08-31
PIs
2

Awarded at BROAD INSTITUTE, INC.

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

8 total · 2 active

NIH #R01CA303137

Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade glioma

Active
Amount
$700K–$800K
Period
2026-06-05 → 2031-05-31
PIs
2

Awarded at DANA-FARBER CANCER INST

NIH #R01CA262462

Synthetic lethalities to cell cycle disruption in glioma

Active
Amount
$600K–$700K
Period
2022-05-13 → 2027-04-30
PIs
2

Awarded at DANA-FARBER CANCER INST

NIH #U24CA264029

Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing Data

Amount
$300K–$400K
Period
2021-09-20 → 2026-08-31
PIs
2

Awarded at BROAD INSTITUTE, INC.

NIH #R01CA188228

Evolution of gliomas during treatment and resistance

Amount
$700K–$800K
Period
2015-04-01 → 2026-06-30
PIs
3

Awarded at DANA-FARBER CANCER INST

NIH #R01CA219943

Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas

Amount
$500K–$600K
Period
2017-09-01 → 2023-08-31
PIs
2

Awarded at BROAD INSTITUTE, INC.

NIH #R01CA215489

MYB family alterations in pediatric gliomas

Amount
$500K–$600K
Period
2017-04-01 → 2022-03-31
PIs
2

Awarded at DANA-FARBER CANCER INST

NIH #U24CA210978

Center for the comprehensive analysis of somatic copy-number alterations in cancer

Amount
$400K–$500K
Period
2016-09-15 → 2021-08-31
PIs
2

Awarded at BROAD INSTITUTE, INC.

NIH #K08CA122833

High-resolution genome-wide mapping of structural mutations in prostate cancer

Amount
$100K–$200K
Period
2007-06-12 → 2012-05-31
PIs
1

Awarded at DANA-FARBER CANCER INST

Recent Public Signals

  1. New NIH award: Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade glioma2026-06-05
  2. New paper: Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma (Neuro-Oncology)2025-12-13
  3. New NIH award: Synthetic lethalities to cell cycle disruption in glioma2022-05-13

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0001-6303-3609

Professor Insights

Career Trajectory